These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

640 related articles for article (PubMed ID: 23892100)

  • 1. A novel Sin Nombre virus DNA vaccine and its inclusion in a candidate pan-hantavirus vaccine against hantavirus pulmonary syndrome (HPS) and hemorrhagic fever with renal syndrome (HFRS).
    Hooper JW; Josleyn M; Ballantyne J; Brocato R
    Vaccine; 2013 Sep; 31(40):4314-21. PubMed ID: 23892100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A hantavirus pulmonary syndrome (HPS) DNA vaccine delivered using a spring-powered jet injector elicits a potent neutralizing antibody response in rabbits and nonhuman primates.
    Kwilas S; Kishimori JM; Josleyn M; Jerke K; Ballantyne J; Royals M; Hooper JW
    Curr Gene Ther; 2014; 14(3):200-10. PubMed ID: 24867065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction and nonclinical testing of a Puumala virus synthetic M gene-based DNA vaccine.
    Brocato RL; Josleyn MJ; Wahl-Jensen V; Schmaljohn CS; Hooper JW
    Clin Vaccine Immunol; 2013 Feb; 20(2):218-26. PubMed ID: 23239797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for haemorrhagic fever with renal syndrome delivered by intramuscular electroporation.
    Hooper JW; Moon JE; Paolino KM; Newcomer R; McLain DE; Josleyn M; Hannaman D; Schmaljohn C
    Clin Microbiol Infect; 2014 May; 20 Suppl 5():110-7. PubMed ID: 24447183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical evaluation of a fully human, quadrivalent-hantavirus polyclonal antibody derived from a non-human source.
    Brocato RL; Wu H; Kwilas SA; Principe LM; Josleyn M; Shamblin J; Chivukula P; Bausch C; Luke T; Sullivan EJ; Hooper JW
    mBio; 2024 Oct; 15(10):e0160024. PubMed ID: 39258903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA vaccination with the Hantaan virus M gene protects Hamsters against three of four HFRS hantaviruses and elicits a high-titer neutralizing antibody response in Rhesus monkeys.
    Hooper JW; Custer DM; Thompson E; Schmaljohn CS
    J Virol; 2001 Sep; 75(18):8469-77. PubMed ID: 11507192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA vaccine-derived human IgG produced in transchromosomal bovines protect in lethal models of hantavirus pulmonary syndrome.
    Hooper JW; Brocato RL; Kwilas SA; Hammerbeck CD; Josleyn MD; Royals M; Ballantyne J; Wu H; Jiao JA; Matsushita H; Sullivan EJ
    Sci Transl Med; 2014 Nov; 6(264):264ra162. PubMed ID: 25429055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hantavirus pulmonary syndrome.
    Macneil A; Nichol ST; Spiropoulou CF
    Virus Res; 2011 Dec; 162(1-2):138-47. PubMed ID: 21945215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A lethal disease model for hantavirus pulmonary syndrome in immunosuppressed Syrian hamsters infected with Sin Nombre virus.
    Brocato RL; Hammerbeck CD; Bell TM; Wells JB; Queen LA; Hooper JW
    J Virol; 2014 Jan; 88(2):811-9. PubMed ID: 24198421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vesicular Stomatitis Virus-Based Vaccines Provide Cross-Protection against Andes and Sin Nombre Viruses.
    Warner BM; Stein DR; Jangra RK; Slough MM; Sroga P; Sloan A; Frost KL; Booth S; Chandran K; Safronetz D
    Viruses; 2019 Jul; 11(7):. PubMed ID: 31337019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hantaan/Andes virus DNA vaccine elicits a broadly cross-reactive neutralizing antibody response in nonhuman primates.
    Hooper JW; Custer DM; Smith J; Wahl-Jensen V
    Virology; 2006 Mar; 347(1):208-16. PubMed ID: 16378630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Andes virus M genome segment is not sufficient to confer the virulence associated with Andes virus in Syrian hamsters.
    McElroy AK; Smith JM; Hooper JW; Schmaljohn CS
    Virology; 2004 Aug; 326(1):130-9. PubMed ID: 15262501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active and passive vaccination against hantavirus pulmonary syndrome with Andes virus M genome segment-based DNA vaccine.
    Custer DM; Thompson E; Schmaljohn CS; Ksiazek TG; Hooper JW
    J Virol; 2003 Sep; 77(18):9894-905. PubMed ID: 12941899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA vaccines for HFRS: laboratory and clinical studies.
    Schmaljohn CS; Spik KW; Hooper JW
    Virus Res; 2014 Jul; 187():91-6. PubMed ID: 24370868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for hemorrhagic fever with renal syndrome.
    Boudreau EF; Josleyn M; Ullman D; Fisher D; Dalrymple L; Sellers-Myers K; Loudon P; Rusnak J; Rivard R; Schmaljohn C; Hooper JW
    Vaccine; 2012 Mar; 30(11):1951-8. PubMed ID: 22248821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid and specific detection of Sin Nombre virus antibodies in patients with hantavirus pulmonary syndrome by a strip immunoblot assay suitable for field diagnosis.
    Hjelle B; Jenison S; Torrez-Martinez N; Herring B; Quan S; Polito A; Pichuantes S; Yamada T; Morris C; Elgh F; Lee HW; Artsob H; Dinello R
    J Clin Microbiol; 1997 Mar; 35(3):600-8. PubMed ID: 9041397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential lymphocyte and antibody responses in deer mice infected with Sin Nombre hantavirus or Andes hantavirus.
    Schountz T; Quackenbush S; Rovnak J; Haddock E; Black WC; Feldmann H; Prescott J
    J Virol; 2014 Aug; 88(15):8319-31. PubMed ID: 24829335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA vaccine-generated duck polyclonal antibodies as a postexposure prophylactic to prevent hantavirus pulmonary syndrome (HPS).
    Brocato R; Josleyn M; Ballantyne J; Vial P; Hooper JW
    PLoS One; 2012; 7(4):e35996. PubMed ID: 22558299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innate and adaptive immune responses against human Puumala virus infection: immunopathogenesis and suggestions for novel treatment strategies for severe hantavirus-associated syndromes.
    Klingström J; Smed-Sörensen A; Maleki KT; Solà-Riera C; Ahlm C; Björkström NK; Ljunggren HG
    J Intern Med; 2019 May; 285(5):510-523. PubMed ID: 30663801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human antibody recognizing a quaternary epitope in the Puumala virus glycoprotein provides broad protection against orthohantaviruses.
    Mittler E; Wec AZ; Tynell J; Guardado-Calvo P; Wigren-Byström J; Polanco LC; O'Brien CM; Slough MM; Abelson DM; Serris A; Sakharkar M; Pehau-Arnaudet G; Bakken RR; Geoghegan JC; Jangra RK; Keller M; Zeitlin L; Vapalahti O; Ulrich RG; Bornholdt ZA; Ahlm C; Rey FA; Dye JM; Bradfute SB; Strandin T; Herbert AS; Forsell MNE; Walker LM; Chandran K
    Sci Transl Med; 2022 Mar; 14(636):eabl5399. PubMed ID: 35294259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.